Outcomes in patients with severe cytopenia within 100 days after CAR T-cell therapy
| Outcome | Time after diagnosis of severe cytopenia | Patients with severe cytopenia, n=48 |
| Non-relapse mortality | At 3 months (95% CI) | 6.5% (1.7 to 16.2) |
| At 12 months (95% CI) | 6.5% (1.7 to 16.2) | |
| Overall survival | At 3 months (95% CI) | 80.9% (70.3 to 92.9) |
| At 12 months (95% CI) | 53.6% (40.3 to 71.2) | |
| Progression-free survival | At 3 months (95% CI) | 49.7% (37.1 to 66.5) |
| At 12 months (95% CI) | 20% (10.4 to 38.6) | |
| Relapse incidence | At 3 months (95% CI) | 43.8% (29 to 57.7) |
| At 12 months (95% CI) | 73.5% (55.2 to 85.2) |